GlobeImmune Inc (GBIM)
0.00
USD |
OTCM |
Apr 25, 16:00
GlobeImmune Cash from Operations (TTM): -5.905M for March 31, 2016
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2016 | -5.905M |
| December 31, 2015 | -7.130M |
| September 30, 2015 | -7.765M |
| June 30, 2015 | -8.573M |
| March 31, 2015 | -9.202M |
| December 31, 2014 | -10.05M |
| September 30, 2014 | -7.924M |
| Date | Value |
|---|---|
| June 30, 2014 | -0.3003M |
| March 31, 2014 | 2.190M |
| December 31, 2013 | 3.932M |
| September 30, 2013 | -0.3912M |
| June 30, 2013 | -10.34M |
| March 31, 2013 | -13.94M |
| June 30, 2012 | -16.61M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.00M |
| Oragenics Inc | -7.291M |